CompareMarketResearchRequest a sample
Home / Healthcare / Pen Injector

Healthcare · Market report

Pen Injector Market Size, Share and Forecast 2026-2036

The global pen injector market is worth USD 6.7 bn in 2026 and is forecast to reach USD 17.3 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Disposable is the largest by type segment.

USD 6.7 bnMarket size 2026
USD 17.3 bnForecast 2036
10.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global pen injector market is worth USD 6.7 bn in 2026 and is forecast to reach USD 17.3 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Disposable is the largest by type segment.

ScopePen-type injectors for insulin, GLP-1, growth hormone, fertility and other drugs: disposable and reusable pens supplied to drug makers and patients.
IndustryHealthcare
Value 2025USD 6.0 bn
Value 2026USD 6.7 bn
Value 2036USD 17.3 bn
CAGR 2026-203610.0%
Volume 20262,900 million units
Volume 20367,910 million units
Average price 2026USD 2.30 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Pen Injector market size and forecast, 2026-2036

Exhibit 1The global pen injector market is forecast to grow from USD 6.7 bn in 2026 to USD 17.3 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 10.0%
Pen Injector market value, 2025 to 2036Market value by year. 2025: USD 6.0 bn; 2026: USD 6.7 bn; 2027: USD 7.3 bn; 2028: USD 8.1 bn; 2029: USD 8.9 bn; 2030: USD 9.8 bn; 2031: USD 10.7 bn; 2032: USD 11.8 bn; 2033: USD 13.0 bn; 2034: USD 14.3 bn; 2035: USD 15.7 bn; 2036: USD 17.3 bn. Compound annual growth rate 2026 to 2036: 10.0%.20256.7 bn202610.7 bn203117.3 bn203610.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 6.7 bn
2027USD 7.3 bn
2028USD 8.1 bn
2029USD 8.9 bn
2030USD 9.8 bn
2031USD 10.7 bn
2032USD 11.8 bn
2033USD 13.0 bn
2034USD 14.3 bn
2035USD 15.7 bn
2036USD 17.3 bn

Pen Injector market segmentation

By type

Exhibit 2Disposable is the largest segment by type, with 58.0% of 2026 revenueEstimated share of 2026 global revenue, by type
Pen Injector market share by type, 2026Share of 2026 revenue by type. Disposable: 58.0%; Reusable: 30.0%; Smart and connected: 12.0%.Disposable58.0%Reusable30.0%Smart and connected12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Disposable58.0%62.5%USD 3.9 bn10.8%
Reusable30.0%21.4%USD 2.0 bn6.3%
Smart and connected12.0%16.1%USD 799 mn13.3%

By drug

Exhibit 3GLP-1 and obesity adds the most revenue by drug, growing from USD 2.8 bn in 2026 to USD 10.7 bn by 2036Estimated revenue in USD by drug, 2026 and 2036 forecast
Pen Injector market by drug, 2026 and 2036Revenue by drug in 2026 and 2036. GLP-1 and obesity: USD 2.8 bn in 2026, USD 10.7 bn in 2036, change +283%; Insulin: USD 2.3 bn in 2026, USD 3.5 bn in 2036, change +54%; Osteoporosis and other: USD 799 mn in 2026, USD 1.6 bn in 2036, change +104%; Growth hormone: USD 466 mn in 2026, USD 868 mn in 2036, change +86%; Fertility: USD 333 mn in 2026, USD 565 mn in 2036, change +70%.20262036 forecastChangeGLP-1 and obesity+283%2.8 bn10.7 bnInsulin+54%2.3 bn3.5 bnOsteoporosis and other+104%799 mn1.6 bnGrowth hormone+86%466 mn868 mnFertility+70%333 mn565 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Insulin34.0%20.2%USD 2.3 bn4.4%
GLP-1 and obesity42.0%62.0%USD 2.8 bn14.4%
Growth hormone7.0%5.0%USD 466 mn6.4%
Fertility5.0%3.3%USD 333 mn5.4%
Osteoporosis and other12.0%9.5%USD 799 mn7.4%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Home care70.0%73.9%USD 4.7 bn10.6%
Hospitals18.0%15.1%USD 1.2 bn8.1%
Clinics and long-term care12.0%11.0%USD 799 mn9.1%

By drug category

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Insulin and diabetes drugs48.0%42.0%USD 3.2 bn8.5%
Growth hormone14.0%13.0%USD 932 mn9.2%
Fertility and osteoporosis drugs14.0%14.0%USD 932 mn10.0%
GLP-1 and weight management24.0%31.0%USD 1.6 bn12.8%

By channel

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Retail pharmacy48.0%44.0%USD 3.2 bn9.1%
Hospital pharmacy22.0%20.0%USD 1.5 bn9.0%
Online pharmacy30.0%36.0%USD 2.0 bn12.0%

Top 25 countries for pen injector by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 79.5% of 2026 revenue and the 25 countries below together hold 94.7%.

Exhibit 4United States is the largest country market at USD 2.4 bn in 2026, and the three largest countries hold 53.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Pen Injector market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.4 bn, 36.0%; China: USD 799 mn, 12.0%; Germany: USD 333 mn, 5.0%; Japan: USD 333 mn, 5.0%; United Kingdom: USD 266 mn, 4.0%; France: USD 266 mn, 4.0%; India: USD 266 mn, 4.0%; Brazil: USD 233 mn, 3.5%; Italy: USD 200 mn, 3.0%; Canada: USD 200 mn, 3.0%.United States2.4 bn 36.0%China799 mn 12.0%Germany333 mn 5.0%Japan333 mn 5.0%United Kingdom266 mn 4.0%France266 mn 4.0%India266 mn 4.0%Brazil233 mn 3.5%Italy200 mn 3.0%Canada200 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.4 bn36.0%USD 6.4 bn10.3%
2ChinaUSD 799 mn12.0%USD 2.8 bn13.3%
3GermanyUSD 333 mn5.0%USD 674 mn7.3%
4JapanUSD 333 mn5.0%USD 674 mn7.3%
5United KingdomUSD 266 mn4.0%USD 587 mn8.2%
6FranceUSD 266 mn4.0%USD 536 mn7.2%
7IndiaUSD 266 mn4.0%USD 846 mn12.3%
8BrazilUSD 233 mn3.5%USD 570 mn9.3%
9ItalyUSD 200 mn3.0%USD 397 mn7.1%
10CanadaUSD 200 mn3.0%USD 484 mn9.2%
11SpainUSD 136 mn2.0%USD 330 mn9.3%
12NetherlandsUSD 119 mn1.8%USD 290 mn9.3%
13MexicoUSD 105 mn1.6%USD 256 mn9.3%
14AustraliaUSD 100 mn1.5%USD 244 mn9.3%
15TurkeyUSD 91 mn1.4%USD 221 mn9.3%
16RussiaUSD 81 mn1.2%USD 195 mn9.2%
17PolandUSD 71 mn1.1%USD 171 mn9.2%
18South KoreaUSD 62 mn0.9%USD 150 mn9.3%
19SwedenUSD 51 mn0.8%USD 123 mn9.2%
20SwitzerlandUSD 43 mn0.7%USD 104 mn9.1%
21BelgiumUSD 38 mn0.6%USD 92 mn9.2%
22ArgentinaUSD 36 mn0.5%USD 88 mn9.4%
23Saudi ArabiaUSD 29 mn0.4%USD 71 mn9.2%
24DenmarkUSD 26 mn0.4%USD 62 mn9.1%
25AustriaUSD 23 mn0.3%USD 55 mn9.3%
Rest of worldUSD 355 mn5.3%USD 883 mn9.5%
Exhibit 5United States and China account for 56% of the USD 10.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Pen Injector market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 6.7 bn. United States: +USD 4.0 bn; China: +USD 2.0 bn; India: +USD 580 mn; Germany: +USD 341 mn; Japan: +USD 341 mn; 20 other countries: +USD 2.8 bn; Rest of world: +USD 528 mn. Market value 2036: USD 17.3 bn.Market value 20266.7 bnUnited States+4.0 bnChina+2.0 bnIndia+580 mnGermany+341 mnJapan+341 mn20 other countries+2.8 bnRest of world+528 mnMarket value 203617.3 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Novo Nordisk
  • Eli Lilly
  • Ypsomed
  • SHL Medical
  • Phillips-Medisize

Group 2: Regional and specialist players

  • Becton Dickinson
  • Owen Mumford
  • Haselmeier
  • Sanofi
  • Nemera
  • West Pharmaceutical Services
  • Terumo
  • Halozyme

Group 3: Emerging and niche players

  • Gan & Lee
  • Biocon
  • Biocorp
  • Subcuject
  • Julphar
  • Tonghua Dongbao

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the pen injector market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 10.0% is calculated from the resulting values.

The market is divided by type, by drug, by end user, by drug category, by channel. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the pen injector market?

The global pen injector market is estimated at USD 6.0 bn in 2025 and USD 6.7 bn in 2026.

How fast will the pen injector market grow?

It is forecast to reach USD 17.3 bn by 2036, a compound annual growth rate of 10.0% from 2026, an increase of USD 10.6 bn.

Which country is the largest market for pen injector?

United States is the largest market by revenue at USD 2.4 bn in 2026, 36.0% of the global total. The three largest countries together hold 53.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 13.3% a year from 2026 to 2036.

Which pen injector segment is largest?

In the by type split, Disposable is the largest segment with 58.0% of 2026 revenue.

Who are the leading pen injector companies?

Global leaders include Novo Nordisk, Eli Lilly, Ypsomed, SHL Medical.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Patient-Specific Surgical Implant Design Peptide Receptor Radionuclide Therapy (PRRT) →

All Healthcare markets →

Request a sample